• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Kane Biotech Inc

+ Add to Watchlist

KA4:GR

0.056 EUR 0.0000.00%

As of 09:08:31 ET on 07/10/2014.

Snapshot for Kane Biotech Inc (KA4)

Open: 0.056 Day's Range: 0.056 - 0.056 Volume: 0
Previous Close: 0.056 52wk Range: 0.035 - 0.087 1-Yr Rtn: +9.80%

Stock Chart for KA4

No chart data available.
  • KA4:GR 0.056
  • 1D
  • 1M
  • 1Y
0.056
Interactive KA4 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for KA4

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 4.58
Shares Outstanding (M) 81.87
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for KA4

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for KA4

Kane Biotech Inc. is involved in the research and development of products to prevent and disperse bacterial biofilms. The Company's technology includes targets, methods, and processes involved in the formation of biofilms. Kane's technology has potential to improve the ability to prevent and/or destroy biofilms, in several medical and industrial applications.

Gordon FroehlichPresident/CEOMark MatthewsonChief Financial Officer
More Company Profile & Key Executives for KA4

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil